PRIME EducationPRIME Education Facebook ad: “Tenosynovial Giant Cell Tumor care updates - Watch & Learn…”
Ran for 50 days, from August 17 to October 6, 2026, the last day Crush saw it.
Run by PRIME Education on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1076684731511815
- Platforms
- Facebook, Instagram, Audience Network, Messenger and Threads
- Relaunches
- 0
Ad text
Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT | 1.0-hour CME/CE | Clinical Connections On-Demand Video | #MedEd #cme #TenosynovialGiantCellTumor
Where the ad sends people
primeinc.org
Tenosynovial Giant Cell Tumor care updates - Watch & Learn Today!
Over the past decade, novel CSF1 receptor inhibitors have expanded treatment options for patients with tenosynovial giant cell tumor (TGCT). Advance...
Learn more: primeinc.org(opens in a new tab)
